ACIP Meeting Report – Jan 5th 2022

  • News

Following the FDA update on the Emergency Use Authorization (EUA) Fact Sheet for Pfizer-BioNTech COVID-19 vaccine on January 3rd 2022, Advisory Committee on Immunization Practices (ACIP) met to review safety data on this vaccine in children
and adolescents for the purpose of voting on a recommendation to extend use of the booster dose to 12-15yo adolescents.

To view the CDC ACIP Meeting Report from January 5th 2022, click here.

Close Menu